Gram I T, Macaluso M, Stalsberg H
Institute of Community Medicine, University of Tromsø, Norway.
Acta Obstet Gynecol Scand. 1998 Feb;77(2):228-32.
To investigate the influence of screening history on the diagnosis of cervical intraepithelial neoplasia grade three (CIN III) and cervical cancer in an opportunistic screening program.
Follow-up study of women with a negative Pap-smear at entry.
Records from 41212 women pertaining to cervical specimens in the Pathology Registry of the University Hospital in Tromsø.
During the 175,673 person-years (pyr) of observation, 396 incident cases (379 of CIN III and 17 of cervical cancer) were identified. The age specific incidence rate was highest among women who were 25 to 29 years old (396 per 100,000 pyr). A Poisson multiple regression model yielded statistically significant positive associations between time since last negative Pap-smear and the incidence of CIN III and cervical cancer. Most CIN III cases were diagnosed subsequently to a CIN I or CIN II diagnosis. Including only women with a CIN III diagnosis directly after a negative Pap-smear in the analyses revealed that women with less than two years (Relative rate (RR)= 1.O; 95% CI 0.7-1.4) and three years (RR=0.8; 95% CI 0.4-1.4) since their last negative Pap-smear were not at an increased risk compared with the women with a negative Pap-smear within the last year. Women with three or more years since their last negative Pap-smear were at an increased risk (RR=1.3; 95% CI 0.6 3.2) for CIN III. No meaningful association between number of negative specimens and the risk of CIN III was revealed.
This study indicates that time since last negative Pap-smear does, while number of such does not, influence the risk of CIN III and cervical cancer in an opportunistic screening.
在机会性筛查项目中,调查筛查史对宫颈上皮内瘤变3级(CIN III)和宫颈癌诊断的影响。
对入组时巴氏涂片阴性的女性进行随访研究。
来自特罗姆瑟大学医院病理登记处的41212名女性的宫颈标本记录。
在175673人年的观察期内,共识别出396例新发病例(379例CIN III和17例宫颈癌)。年龄别发病率在25至29岁的女性中最高(每100000人年396例)。泊松多元回归模型显示,自上次巴氏涂片阴性以来的时间与CIN III和宫颈癌的发病率之间存在统计学上显著的正相关。大多数CIN III病例是在CIN I或CIN II诊断之后被诊断出来的。在分析中仅纳入在巴氏涂片阴性后直接诊断为CIN III的女性,结果显示,自上次巴氏涂片阴性以来不到两年(相对率(RR)=1.0;95%置信区间0.7 - 1.4)和三年(RR = 0.8;95%置信区间0.4 - 1.4)的女性与过去一年内巴氏涂片阴性的女性相比,风险并未增加。自上次巴氏涂片阴性以来三年或更长时间的女性患CIN III的风险增加(RR = 1.3;95%置信区间0.6 - 3.2)。未发现阴性标本数量与CIN III风险之间存在有意义的关联。
本研究表明,在机会性筛查中,自上次巴氏涂片阴性以来的时间会影响CIN III和宫颈癌的风险,而阴性标本数量则不会。